AGL 38.41 Decreased By ▼ -0.07 (-0.18%)
AIRLINK 199.40 Decreased By ▼ -3.62 (-1.78%)
BOP 10.00 Decreased By ▼ -0.17 (-1.67%)
CNERGY 6.45 Decreased By ▼ -0.09 (-1.38%)
DCL 9.30 Decreased By ▼ -0.28 (-2.92%)
DFML 38.90 Decreased By ▼ -1.12 (-2.8%)
DGKC 98.50 Increased By ▲ 0.42 (0.43%)
FCCL 35.38 Increased By ▲ 0.42 (1.2%)
FFBL 86.80 Increased By ▲ 0.37 (0.43%)
FFL 13.71 Decreased By ▼ -0.19 (-1.37%)
HUBC 129.49 Decreased By ▼ -2.08 (-1.58%)
HUMNL 13.95 Decreased By ▼ -0.07 (-0.5%)
KEL 5.36 Decreased By ▼ -0.25 (-4.46%)
KOSM 7.36 Increased By ▲ 0.09 (1.24%)
MLCF 45.75 Increased By ▲ 0.16 (0.35%)
NBP 61.60 Decreased By ▼ -4.78 (-7.2%)
OGDC 217.60 Decreased By ▼ -3.16 (-1.43%)
PAEL 39.61 Increased By ▲ 1.13 (2.94%)
PIBTL 8.59 Decreased By ▼ -0.32 (-3.59%)
PPL 192.69 Decreased By ▼ -5.19 (-2.62%)
PRL 40.80 Increased By ▲ 1.77 (4.53%)
PTC 25.60 Increased By ▲ 0.13 (0.51%)
SEARL 107.55 Increased By ▲ 4.50 (4.37%)
TELE 8.82 Decreased By ▼ -0.20 (-2.22%)
TOMCL 36.39 Decreased By ▼ -0.02 (-0.05%)
TPLP 14.25 Increased By ▲ 0.50 (3.64%)
TREET 25.16 Increased By ▲ 0.04 (0.16%)
TRG 56.80 Decreased By ▼ -1.24 (-2.14%)
UNITY 33.54 Decreased By ▼ -0.13 (-0.39%)
WTL 1.64 Decreased By ▼ -0.07 (-4.09%)
BR100 11,806 Decreased By -84.4 (-0.71%)
BR30 36,801 Decreased By -555.6 (-1.49%)
KSE100 110,166 Decreased By -904.4 (-0.81%)
KSE30 34,632 Decreased By -276.8 (-0.79%)

LAHORE: Pakistan Cricket Board (PCB) and New Zealand Cricket (NZC) have mutually agreed to bring forward the tour of New Zealand men’s side to Pakistan by a day.

The first Test of the two-match series will now commence on 26th December at the National Bank Cricket arena Karachi and the second will be played in Multan from 3rd January. The three ODIs will be played on 10, 12 and 14 January in Karachi.

Schedule of New Zealand’s tour of Pakistan:

First Test–December 26-30 at National Bank Cricket Arena Karachi

Second Test -January 3-7 at Multan Cricket Stadium

First ODI –10th January at National Bank Cricket Arena Karachi.

Copyright Business Recorder, 2022

Comments

Comments are closed.